Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry

被引:71
作者
Dai, GW
Wei, XH
Liu, ZF
Liu, SJ
Marcucci, G
Chan, KK
机构
[1] Ohio State Univ, CCC, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Div Hematol & Oncol, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med & Publ Hlth, Div Human Canc Genet, Columbus, OH 43210 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 825卷 / 02期
关键词
pharmacokinetics; tandem mass spectrometry; metabolism; Bcl-2; antisense; N-in-one quantification;
D O I
10.1016/j.jchromb.2005.05.049
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A novel ion-pair reversed phase electrospray ionization (IP-RP-ESI) liquid chromatography-mass spectrometry (LC-MS) method has been developed for identification and quantification of Bcl-2 antisense phosphorothioate oligonucleotides G3139 and metabolites in plasma. This method utilized solid phase extraction for desalting and matrix removal and detection by an ion trap mass spectrometer. Resolution was accomplished on a micro C18 column eluted with a mobile phase consisting of hexafluoro-2-propanol and triethylamine in methanol at 50 degrees C. Five G3139 metabolites were identified in plasma and urine from treated patients and rats. A cassette HPLC-MS/MS quantification method for G3139 and three metabolites was developed and validated with a limit of quantification (LOQ) of 17.6 nM in human and rat plasma with acceptable precision and accuracy. Plasma pharmacokinetics of G3139 and metabolites in these species were described. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:201 / 213
页数:13
相关论文
共 52 条
[1]  
Ahmad A, 2004, METHOD ENZYMOL, V387, P230
[2]   New procedure for the use of high-performance liquid chromatography electrospray ionization mass spectrometry for the analysis of nucleotides and oligonucleotides [J].
Apffel, A ;
Chakel, JA ;
Fischer, S ;
Lichtenwalter, K ;
Hancock, WS .
JOURNAL OF CHROMATOGRAPHY A, 1997, 777 (01) :3-21
[3]   Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry [J].
Apffel, A ;
Chakel, JA ;
Fischer, S ;
Lichtenwalter, K ;
Hancock, WS .
ANALYTICAL CHEMISTRY, 1997, 69 (07) :1320-1325
[4]  
CHAN KK, 1982, DRUG METAB DISPOS, V10, P474
[5]   Determination of Rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection [J].
Chavez-Eng, CM ;
Constanzer, ML ;
Matuszewski, BK .
JOURNAL OF CHROMATOGRAPHY B, 2000, 748 (01) :31-39
[6]  
Chi KN, 2001, CLIN CANCER RES, V7, P3920
[7]   A nonradioisotope approach to study the in vivo metabolism of phosphorothioate oligonucleotides [J].
Cohen, AS ;
Bourque, AJ ;
Wang, BH ;
Smisek, DL ;
Belenky, A .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (01) :13-22
[8]  
COTTER FE, 1994, ONCOGENE, V9, P3049
[9]  
Dai Guo Wei, 2003, Proceedings of the American Association for Cancer Research Annual Meeting, V44, P1299
[10]   Cellular uptake and intracellular levels of the Bcl-2 antisense G3139 in cultured cells and treated patients with acute myeloid leukemia [J].
Dai, GW ;
Chan, KK ;
Liu, SJ ;
Hoyt, D ;
Whitman, S ;
Kilsovic, M ;
Shen, TS ;
Caligiuri, MA ;
Byrd, J ;
Grever, M ;
Marcucci, G .
CLINICAL CANCER RESEARCH, 2005, 11 (08) :2998-3008